Late Night Market Recap Winners Losers and Everything Between

 Night.Owl
 
  Night.Owl
 
Follow  Message
 
 
 
Night.Owl masters market recaps, offering sharp analysis that uncovers hidden patterns and key moves. Stay ahead with Night.Owl’s expert insights.
 

•  10 Nov 2025
 

•   APLD  
   
  -0.70%
•   ASTS  
   
  +7.60%
•   BTDR  
   
  -33.09%
•   BYND  
   
  -8.96%
•   CCL  
   
  -3.79%

$COGT emerged as the day undisputed champion, with shares of Cogent Biosciences rocketing an astounding 119% to hit a seven-year high. The biotech company announced positive Phase 3 PEAK trial results for bezuclastinib, its investigational treatment for gastrointestinal stromal tumors. The experimental stomach cancer drug generated such enthusiasm that trading volume reached over 21 million shares, with options activity hitting noteworthy levels as investors rushed to position themselves around the breakthrough clinical data. The stock soared as high as 135% during the session before settling at triple-digit gains.

$BYND faced a rough Monday as Beyond Meat shares sank following third-quarter earnings guidance that disappointed the Street. The plant-based meat company reported a non-GAAP loss of 47 cents per share, missing estimates by four cents, though revenue of 70.22 million dollars managed to beat expectations slightly. The CEO attempted to highlight three important building blocks for the company's future, but investors weren't buying the optimism as the stock dropped 3.6 percent on massive volume exceeding 97 million shares. The decline in revenue continues to weigh on investor sentiment despite management's restructuring efforts.

$APLD Applied Digital subsidiary APLD ComputeCo announced plans for a substantial 2.35 billion dollar senior secured notes offering due in 2030. The private placement drew attention from institutional investors, with options activity revealing a bullish stance among big money players. Volume came in at nearly 22.5 million shares as traders digested the implications of the debt offering for the company's data center and high-performance computing operations.

$BTDR suffered the day steepest decline, plummeting 19.74% after Bitdeer Technologies reported GAAP earnings per share of negative 1.28 dollars, missing estimates by a whopping 1.10 dollars. While revenue of 169.71 million dollars beat expectations by over 14 million dollars, the significant earnings miss overshadowed the top-line beat. Volume reached 11.5 million shares as investors sold off positions in response to the disappointing bottom-line results.

$CCL Carnival continued its impressive six-month run that's seen the stock gain 21 percent since spring. The cruise operator announced that Club Travalia, its vacation membership club, has booked over 3,000 reservations for 2025, marking a major milestone. Booming bookings and rising yields have prompted upgraded guidance for 2025, with analysts pointing to stronger fundamentals as the company capitalizes on robust demand for cruise vacations. Trading volume hit 17.5 million shares as momentum traders piled in.

$ASTS AST SpaceMobile missed earnings expectations with a GAAP loss of 45 cents per share, 18 cents worse than estimates. Revenue of 14.73 million dollars also fell short of projections by over seven million dollars. The satellite communications company saw its valuation pressured further by broader tech sector pullback came on volume of 7.6 million shares as investors reassessed their positions.

$DELL analysts suggesting the stock presents a buying opportunity after finding support following recent losses. Dell Technologies continues to trade at what many consider a deep discount while AI server demand and new product launches fuel strong growth prospects. The hammer chart pattern indicated technical support, and several guru-based fundamental analysis models rated the stock favorably. Still, the broader tech selloff weighed on shares even as Wall Street maintains generally bullish views on the hardware giant.

$DIS Disney streaming gains and strategic initiatives continue to show promise, though softness in the parks business remains a concern for some analysts. The stock attracted attention from long-term investors as Wall Street average brokerage recommendation suggests adding to positions, though some caution that parks weakness warrants a wait-and-see approach before the earnings release.

$GM hit a fresh 52-week high, crossing above the average analyst 12-month target price of 69.78 dollars to trade at 70.75 dollars per share. General Motors found itself on multiple broker-favored stock lists, with analysts highlighting strong upgrades and earnings momentum despite ongoing concerns about auto tariffs that have added billions in costs across the industry. The breakout above technical resistance on volume of over six million shares suggests investors remain confident.

$LLY continued to attract analyst attention, with 12 analysts releasing ratings over the past three months presenting perspectives ranging from bullish to bearish. The pharmaceutical giant volume came in at nearly five million shares as investors weighed the pipeline prospects and market position in the weight loss and diabetes treatment space. The strength stood in contrast to broader healthcare sector weakness, underscoring its status as a defensive growth play in uncertain times.

View All Headlines